𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver transplantation and nonalcoholic fatty liver disease

✍ Scribed by Kymberly D. Watt

Book ID
115554572
Publisher
Wiley (John Wiley & Sons)
Year
2012
Tongue
English
Weight
175 KB
Volume
1
Category
Article
ISSN
2046-2484

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Nonalcoholic fatty liver disease and liv
Nonalcoholic fatty liver disease and liver transplantation
✍ Paul Angulo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 229 KB

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre

Nonalcoholic fatty liver disease after l
Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
✍ Kanthi Yalamanchili; Sherif Saadeh; GΓΆran B. Klintmalm; Linda W. Jennings; Gary πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples

De novo nonalcoholic fatty liver disease
De novo nonalcoholic fatty liver disease after liver transplantation
✍ Suk Seo; Kalyani Maganti; Manjit Khehra; Rajendra Ramsamooj; Alexander Tsodikov; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 79 KB

Hepatic steatosis is a recognized problem in patients after orthotopic liver transplant (OLT). However, de novo development of nonalcoholic fatty liver disease (NAFLD) has not been well described. The aim of this study was to determine the prevalence and predictors of de novo NAFLD after OLT. A retr

De Novo nonalcoholic fatty liver disease
De Novo nonalcoholic fatty liver disease after liver transplantation
✍ Manal F. Abdelmalek; Anna Mae Diehl πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

Achieving long-term graft survival and mortality is the primary goal of liver transplantation (LT). However, disease recurrence remains a stumbling block, especially among patients with hepatitis C. In such patients, worse outcomes may be associated with comorbidities (i.e., hyperlipidemia, hyperten

Development of nonalcoholic fatty liver
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
✍ Melissa J. Contos; Wendy Cales; Richard K. Sterling; Velimir A. Luketic; Mitchel πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 500 KB

Many subjects with cryptogenic cirrhosis have underlying nonalcoholic steatohepatitis (NASH). The natural history of NASH-related cryptogenic cirrhosis after orthotopic liver transplantation (OLT) is not well defined. A primarily retrospective study of patients with the clinical histological phenoty